Despite these obstacles, the exploration of liquid biopsy methods across all clinical stages of intracranial tumors, from early identification to surveying recurrence, remains highly significant and timely.
← all excerpts
Innovation in Non-Invasive Diagnosis and Disease Monitoring for Meningiomas.
1
—
—